LifeSci Venture Partners
Invests in early-stage life sciences companies developing breakthrough therapeutics, medical devices, and healthcare technologies
Check Size$500K – $15M
StagesSeed, Series A, Series B
LocationUnited States
Data quality51good
Investment thesis
Invests in early-stage life sciences companies developing breakthrough therapeutics, medical devices, and healthcare technologies
60 confidence · stated by fund
Investment profile
- Stages
- Seed, Series A, Series B
- Sectors
- Biotechnology, Medical Devices, Digital Health, Pharmaceuticals
Frequently asked questions
- What does LifeSci Venture Partners invest in?
- LifeSci Venture Partners is a seed, series a, series b stage Biotechnology, Medical Devices, Digital Health, Pharmaceuticals investor, typically writing $500K – $15M checks, primarily investing in United States. Their thesis: Invests in early-stage life sciences companies developing breakthrough therapeutics, medical devices, and healthcare technologies
- What check size does LifeSci Venture Partners write?
- LifeSci Venture Partners typically writes $500K – $15M checks at the Seed, Series A, Series B stage in Biotechnology, Medical Devices, Digital Health, Pharmaceuticals.
- How do I reach out to LifeSci Venture Partners?
- Use DryPowder's AI fund matching to see how your startup aligns with LifeSci Venture Partners's thesis and focus areas (Biotechnology, Medical Devices, Digital Health, Pharmaceuticals) — it returns a fit score and specific talking points for your outreach.